TrialPloS one2014

Predictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3.

Claus Niederau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.